Markets

Aroa Biosurgery in trading halt for capital raise

Rebecca Stevenson
Tue, 27 Jul 2021

Aroa has five products approved for sale in the US. (Image: Supplied)

Rebecca Stevenson
Tue, 27 Jul 2021

New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

Try free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
A custom library of your saved stories
An industry-leading search engine
Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Support quality New Zealand journalism by subscribing today.

Find out more

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets

Wake Up Call: Covid testing for the Auckland border

Staff reporters | Fri, 17 Sep 2021

Sites have been set up near border crossings for workers to pick up and drop off saliva tests.

Coronavirus

Bar owner borrowed $30k to cover wage subsidy delays

Michael Andrew | Fri, 17 Sep 2021

Shaneel Sudhakar faced a 22-day delay in payment of the wage subsidy.

Opinion

Bridgecorp’s death knell a timely warning

Paul McBeth | Fri, 17 Sep 2021

A new generation of investors would do well to wander through the corporate graveyard of yesteryear.

Aroa Biosurgery in trading halt for capital raise

Not convinced yet?

Your company has a subscription

Team